This has nothing to do with the occult or design, but should be seen. I've been working on some stuff, so I will return to blogging shortly.
EDIT — After some discussion with
A division of the pharmaceutical giant Bayer in the 1980s sold a medicine to Asia and Latin America that carried a high risk of transmitting AIDS while it was selling a new, safer product in the west, The New York Times alleged Thursday.
Cutter Biological wanted to avoid being stuck with large stores of a product that was becoming increasingly unmarketable in the United States and Europe, according to internal company documents obtained by the daily.
The company also sought to save money by honoring several fixed-price contracts with the old product, which was cheaper to produce than the new, safer blood-clotting medicine, the daily said other company records suggest.
"These are the most incriminating internal pharmaceutical industry documents I have ever seen," said Dr. Sidney Wolfe, who as director of the Public Citizen Health Research Group has been investigating the industry's practices for three decades.
There is also a piece from Columbia University and The New York Times, but you need a log-in to read the latter so I'll just post it here for you:
Bayer Named In AIDS Suit
Published: March 18, 1987
LEAD: Bayer A.G., the giant West German chemical company, said today that it had been sued over its sale of hemophilia drugs that may have been infected with the AIDS virus.
Bayer A.G., the giant West German chemical company, said today that it had been sued over its sale of hemophilia drugs that may have been infected with the AIDS virus.
The news sent Bayer's shares tumbling by 12.50 marks, or about $6.90, to 292.50 marks, or $162.50, on the Frankfurt Stock Exchange and pulled the whole market lower.
A Bayer statement said fewer than 20 patients who have been treated with the Factor VIII hemophilia drug have filed liability claims against the company charging that the substance was contaminated with the AIDS virus.
Factor VIII, which is essential for the treatment of hemophiliacs, is made from human blood plasma. The drug is produced by Miles Laboratories Inc., an Elkhart, Ind., subsidiary of Bayer, a Bayer spokesman said.
The liability claims, which were filed both in the United States and Western Europe, are still in a pre-court phase, said the spokesman, who requested anonymity.
He added that the drugs infected with the AIDS virus could have been produced by other pharmaceutical companies and not Bayer. But the Bayer statement did not deny that its product might have been contaminated in the past.
Since early 1985, Bayer has been screening all donated blood plasma for the AIDS virus, the company statement said, and the drug is now believed to be AIDS-free.